» Articles » PMID: 15100443

Large-scale Preparation and Purification of Polyacrylamide-free RNA Oligonucleotides

Overview
Journal RNA
Specialty Molecular Biology
Date 2004 Apr 22
PMID 15100443
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

We present a fast and simple protocol for large-scale preparation and purification of RNA oligonucleotides. RNA oligonucleotides are prepared by in vitro transcription with T7 RNA polymerase from linearized plasmid DNA templates constructed by PCR. In place of denaturing polyacrylamide gel electrophoresis (PAGE), size-exclusion chromatography is employed to purify the RNA oligonucleotide from the transcription mixture yielding >99% pure RNA product. In contrast to PAGE-based purification, the gel filtration method does not require denaturation of the RNA oligonucleotide, which is desirable for larger RNAs, and the product is free of low-molecular-weight acrylamide contaminants, which greatly benefits NMR, crystallographic, and other biophysical studies of large RNAs and RNA-protein complexes.

Citing Articles

Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications.

Leong K, Tham S, Poh C Virol J. 2025; 22(1):71.

PMID: 40075519 PMC: 11900334. DOI: 10.1186/s12985-025-02645-6.


RNA vaccines: The dawn of a new age for tuberculosis?.

Li J, Liu D, Li X, Wei J, Du W, Zhao A Hum Vaccin Immunother. 2025; 21(1):2469333.

PMID: 40013818 PMC: 11869779. DOI: 10.1080/21645515.2025.2469333.


mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends.

Gao Y, Yang L, Li Z, Peng X, Li H Biomark Res. 2024; 12(1):93.

PMID: 39217377 PMC: 11366172. DOI: 10.1186/s40364-024-00644-3.


Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules.

Zhang J, Liu Y, Li C, Xiao Q, Zhang D, Chen Y Pharmaceutics. 2023; 15(9).

PMID: 37765153 PMC: 10536309. DOI: 10.3390/pharmaceutics15092182.


Liquid Chromatography Methods for Analysis of mRNA Poly(A) Tail Length and Heterogeneity.

Gilar M, Doneanu C, Gaye M Anal Chem. 2023; 95(38):14308-14316.

PMID: 37696042 PMC: 10535021. DOI: 10.1021/acs.analchem.3c02552.


References
1.
Lukavsky P, Otto G, Lancaster A, Sarnow P, Puglisi J . Structures of two RNA domains essential for hepatitis C virus internal ribosome entry site function. Nat Struct Biol. 2000; 7(12):1105-10. DOI: 10.1038/81951. View

2.
Lukavsky P, Puglisi J . RNAPack: an integrated NMR approach to RNA structure determination. Methods. 2002; 25(3):316-32. DOI: 10.1006/meth.2001.1244. View

3.
Lukavsky P, Kim I, Otto G, Puglisi J . Structure of HCV IRES domain II determined by NMR. Nat Struct Biol. 2003; 10(12):1033-8. DOI: 10.1038/nsb1004. View

4.
Milligan J, Groebe D, Witherell G, Uhlenbeck O . Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res. 1987; 15(21):8783-98. PMC: 306405. DOI: 10.1093/nar/15.21.8783. View

5.
Shields T, Mollova E, Ste Marie L, Hansen M, Pardi A . High-performance liquid chromatography purification of homogenous-length RNA produced by trans cleavage with a hammerhead ribozyme. RNA. 1999; 5(9):1259-67. PMC: 1369848. DOI: 10.1017/s1355838299990945. View